Top Story

AAO airs concerns about beyond-use dates for repackaged Avastin

May 28, 2015

The American Academy of Ophthalmology has provided comments to the FDA expressing its concern that beyond-use dates for repackaged Avastin may limit the drug’s availability for the treatment of age-related macular degeneration.

The beyond-use dates (BUDs) were included in one of five draft guidance documents issued by the FDA in February to clarify provisions of the Drug Quality and Security Act and Compounding Quality Act. The laws were passed in 2013 in the wake of infectious outbreaks traced to steroids and repackaged Avastin provided at compounding pharmacies.

Business News

Iridex reports revenues of $10.8 million in first quarter

May 28, 2015
Iridex reported $10.8 million in revenues in the first quarter 2015, a 5% increase from $10.3 million in the first quarter 2014, according to a press release.Net income…
In the Journals

Choroidal thickness decreases with age, greater axial length

May 28, 2015
Subfoveal choroidal thickness decreased significantly with age and increased axial length in a group of healthy eyes, according to a study.Investigators evaluated 155…
Corinne Wohl Blog

BLOG: Are your middle managers strong or struggling?

May 28, 2015
Many middle managers did not start out with their current position being their dream job. Circumstances prevailed, and they found themselves being offered or told that…
Business News

$4.9 million grant awarded to support research in retinitis pigmentosa

May 27, 2015
The California Institute of Regenerative Medicine awarded Cedars-Sinai scientist Shaomei Wang, MD, PhD, a grant for $4.9 million to support research in use of neural…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

With anti-VEGF therapy well-established as front-line therapy in the management of age-related macular degeneration and…
More »
Meeting News Coverage Video
VIDEO: Update on microinvasive glaucoma procedures

VIDEO: Update on microinvasive glaucoma procedures

May 24, 2015
MILAN — At the OSN Italy meeting, E. Randy Craven, MD, talks about microinvasive glaucoma procedures, specifically…
More »
morganatic-roan